Company Filing History:
2 out of 3,539 
2 out of 1,746 
2 out of 6 
Years Active: 2023
Title: The Innovations of Timothy Greiner
Introduction
Timothy Greiner is a notable inventor based in Council Bluffs, Iowa. He has made significant contributions to the field of medical research, particularly in the area of lymphoma treatment. With two patents to his name, Greiner's work focuses on improving the survival outcomes for patients diagnosed with mantle cell lymphoma.
Latest Patents
Greiner's latest patents include "Evaluation of mantle cell lymphoma and methods related thereto." This invention provides methods for determining a survival predictor score for subjects with mantle cell lymphoma (MCL). It also offers methods for predicting survival outcomes and selecting appropriate treatments for MCL patients. Another significant patent is "Method for determining lymphoma type and providing treatment." This invention distinguishes between different lymphoma types based on gene expression measurements, specifically differentiating between PMBCL and DLBCL, and further classifying DLBCL subtypes. These distinctions are crucial for developing targeted treatment strategies.
Career Highlights
Throughout his career, Timothy Greiner has worked with prestigious organizations such as the National Institutes of Health, a component of the US Department of Health & Human Services, and the Mayo Foundation for Medical Education and Research. His experience in these institutions has greatly influenced his research and innovations in lymphoma treatment.
Collaborations
Greiner has collaborated with esteemed colleagues, including Louis M. Staudt and Anja Mottok. Their joint efforts have contributed to advancing the understanding and treatment of lymphoma.
Conclusion
Timothy Greiner's innovative work in the field of lymphoma research has the potential to significantly impact patient care and treatment outcomes. His patents reflect a commitment to improving survival rates for individuals diagnosed with this challenging disease.